Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.02 USD | +3.51% | +6.03% | -47.28% |
Sales 2024 * | 238M 303M | Sales 2025 * | 259M 331M | Capitalization | 1.41B 1.8B |
---|---|---|---|---|---|
Net income 2024 * | -80M -102M | Net income 2025 * | -95M -121M | EV / Sales 2024 * | 4.83 x |
Net cash position 2024 * | 263M 336M | Net cash position 2025 * | 214M 272M | EV / Sales 2025 * | 4.62 x |
P/E ratio 2024 * |
-18.6
x | P/E ratio 2025 * |
-15.1
x | Employees | 497 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.66% |
Latest transcript on Immunocore Holdings plc
1 day | +3.51% | ||
1 week | +6.03% | ||
Current month | +6.29% | ||
1 month | -15.72% | ||
3 months | -43.50% | ||
6 months | -49.11% | ||
Current year | -47.28% |
Managers | Title | Age | Since |
---|---|---|---|
Bahija Jallal
CEO | Chief Executive Officer | 62 | 18-12-31 |
Brian DiDonato
DFI | Director of Finance/CFO | 57 | 20-03-31 |
John Trainer
COO | Chief Operating Officer | 50 | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Perez
BRD | Director/Board Member | 59 | 19-08-31 |
John Bell
CHM | Chairman | 72 | 15-02-28 |
Bahija Jallal
CEO | Chief Executive Officer | 62 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 1,184 M€ | +12.25% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.14% | 4 M€ | +14.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-07-03 | 36.02 | +3.51% | 283,323 |
24-07-02 | 34.8 | -4.47% | 345,070 |
24-07-01 | 36.43 | +7.49% | 573,646 |
24-06-28 | 33.89 | +0.33% | 775,516 |
24-06-27 | 33.78 | -0.56% | 393,258 |
Delayed Quote Nasdaq, July 03, 2024 at 01:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.28% | 1.8B | |
+54.07% | 809B | |
+38.59% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+13.40% | 238B | |
+0.61% | 221B | |
+13.24% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- IMCR Stock